| Dr Sameer A Patel, MD | |
|
1812 Verdugo Blvd, Glendale, CA 91208 | |
| (818) 790-7100 | |
| Not Available |
| Full Name | Dr Sameer A Patel |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 1812 Verdugo Blvd, Glendale, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508081530 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Hanford | Hanford, CA | Hospital |
| White Memorial Medical Center | Los angeles, CA | Hospital |
| Usc Verdugo Hills Hospital | Glendale, CA | Hospital |
| Adventist Health Reedley | Reedley, CA | Hospital |
| Keck Hospital Of Usc | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Medical Group Of Wmmc | 0244247864 | 32 |
| Usc Care Medical Group Inc | 0446157747 | 1128 |
| Reedley Community Hospital | 0941460984 | 60 |
| Adventist Health Clearlake Hospital Inc. | 3072421197 | 72 |
| Adventist Health Physicians Network | 3274580972 | 499 |
| Hanford Community Hospital | 7416868377 | 57 |
| Willits Hospital Inc | 7416940697 | 54 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Hanford Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538141627 PECOS PAC ID: 7416868377 Enrollment ID: O20040325000272 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Willits Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356339543 PECOS PAC ID: 7416940697 Enrollment ID: O20040405000843 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Ukiah Adventist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235120676 PECOS PAC ID: 6406816123 Enrollment ID: O20041015000818 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Adventist Health Clearlake Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124018031 PECOS PAC ID: 3072421197 Enrollment ID: O20041112000573 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Usc Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902846306 PECOS PAC ID: 0446157747 Enrollment ID: O20050512000412 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Radiology Medical Group Of Wmmc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831123868 PECOS PAC ID: 0244247864 Enrollment ID: O20060307000489 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Adventist Health Tulare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801366711 PECOS PAC ID: 4385988757 Enrollment ID: O20201221001163 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Entity Name | Reedley Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336167550 PECOS PAC ID: 0941460984 Enrollment ID: O20201224000078 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sameer A Patel, MD P.o. Box 1036, Montrose, CA 91021 Ph: (818) 248-9843 | Dr Sameer A Patel, MD 1812 Verdugo Blvd, Glendale, CA 91208 Ph: (818) 790-7100 |
News Archive
Researchers at St Jude Children's Research Hospital found that toll-like receptor 2 detects the SARS-CoV-2 envelope protein-producing inflammatory cytokines.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
Researchers at Oxford University, UK, have conducted a systematic review of the available studies to address the role of presymptomatic and asymptomatic transmission of SARS-CoV-2.
› Verified 8 days ago
Dr. Jose Alejandro Ospina, MD, PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5642 | |
Dr. Severiano Valenzuela, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1109 S Central Ave, Glendale, CA 91204 Phone: 818-244-4646 | |
Dr. Sepand Salehian, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5642 | |
Linas J Kazlauskas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 720 E Colorado St, Glendale, CA 91205 Phone: 818-500-5885 Fax: 818-241-2946 | |
Taguhi Keshishian, Radiology Medicare: Not Enrolled in Medicare Practice Location: 1577 E Chevy Chase Dr Ste 300, Glendale, CA 91206 Phone: 818-590-8557 | |
Christina T Wade, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1812 Verdugo Rd, Verdugo Hills Hospital, Glendale, CA 91208 Phone: 818-790-7100 | |
Dr. Steven Jc Wong, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 624 S. Central Ave., Glendale, CA 91204 Phone: 818-241-3369 Fax: 818-242-0640 |